TNF-α compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia

Journal of Immunology

Volumn 167, Issue 9, 2001, Pages 5240-5246

  Rijneveld, A W ^a   Florquin, S ^a   Branger, J ^a   Speelman, P ^a   Van Deventer, S J H ^a   Van Der Poll, T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRANULOCYTOSIS; HISTOPATHOLOGY; HOST RESISTANCE; LOBAR PNEUMONIA; LUNG INFILTRATE; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SURVIVAL;

EID: 0035500644     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.9.5240     Document Type: Article

References (37)

1. Treatment of pneumonia and its implications for antimicrobial resistance: Introduction
2. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society: Medical Section of the American Lung Association
3. Drug-resistant Streptococcus pneumoniae Clin
4. Limiting the spread of penicillin-resistant Streptococcus pneumoniae: Experiences from the south Swedish pneumococcal intervention project
5. Overview of resistance in the 1990s
6. Cytokines and anticytokines in the pathogenesis of sepsis
7. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever
8. Tumor necrosis factor in the pathophysiology of infection and sepsis
9. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings
10. Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice
11. Interleukin 1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition
12. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
13. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia
14. In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor a and nitric oxide
15. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia
16. Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice
17. Biologic basis for interleukin-1 in disease
18. The interleukin-1 receptor complex and interleukin-1 signal transduction
19. The interleukin-1 system: Receptors, ligands and signals
20. Interleukin 1 signaling occurs exclusively via the type I receptor
21. Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response
22. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1
23. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia
24. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia
25. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia
26. Role of γ interferon in the pathogenesis of bacteremic pneumococcal pneumonia
27. Compartmentalized cytokine production within the human lung in unilateral pneumonia
28. Interleukin-1β in pleural fluids of different etiologies: Its role as inflammatory mediator in empyema
29. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections
30. Interleuken 1: An important mediator of host resistance against Pneumocystis carinii
31. Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1β-deficient mice
32. Interleukin-1-induced lung neutrophil accumulation and oxygen metabolite-mediated lung leak in rats
33. Cytokine-induced neutrophil chemoattractant is necessary for interleukin-1-induced lung leak in rats
34. Intratracheal injection of endotoxin and cytokines
35. The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin and IL-1-induced acute inflammation
36. Intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation
37. Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment